240 related articles for article (PubMed ID: 26239295)
21. Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine.
Rofina JE; Singh K; Skoumalova-Vesela A; van Ederen AM; van Asten AJ; Wilhelm J; Gruys E
Amyloid; 2004 Jun; 11(2):90-100. PubMed ID: 15478464
[TBL] [Abstract][Full Text] [Related]
22. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
23. A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.
Brici D; Götz J; Nisbet RM
J Alzheimers Dis; 2018; 61(3):899-905. PubMed ID: 29332046
[TBL] [Abstract][Full Text] [Related]
24. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
25. Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study.
Iida MA; Farrell K; Walker JM; Richardson TE; Marx GA; Bryce CH; Purohit D; Ayalon G; Beach TG; Bigio EH; Cortes EP; Gearing M; Haroutunian V; McMillan CT; Lee EB; Dickson DW; McKee AC; Stein TD; Trojanowski JQ; Woltjer RL; Kovacs GG; Kofler JK; Kaye J; White CL; Crary JF
Acta Neuropathol Commun; 2021 Aug; 9(1):134. PubMed ID: 34353357
[TBL] [Abstract][Full Text] [Related]
26. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
Armstrong RA
Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
[TBL] [Abstract][Full Text] [Related]
28. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
29. Region-specific expression of tau, amyloid-β protein precursor, and synaptic proteins at physiological condition or under endoplasmic reticulum stress in rats.
Lin L; Yang SS; Chu J; Wang L; Ning LN; Zhang T; Jiang Q; Tian Q; Wang JZ
J Alzheimers Dis; 2014; 41(4):1149-63. PubMed ID: 24787918
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
[TBL] [Abstract][Full Text] [Related]
31. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice.
Kambe T; Motoi Y; Inoue R; Kojima N; Tada N; Kimura T; Sahara N; Yamashita S; Mizoroki T; Takashima A; Shimada K; Ishiguro K; Mizuma H; Onoe H; Mizuno Y; Hattori N
Neurobiol Dis; 2011 Jun; 42(3):404-14. PubMed ID: 21324362
[TBL] [Abstract][Full Text] [Related]
32. β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals.
Wu HY; Kuo PC; Wang YT; Lin HT; Roe AD; Wang BY; Han CL; Hyman BT; Chen YJ; Tai HC
J Neuropathol Exp Neurol; 2018 Sep; 77(9):814-826. PubMed ID: 30016458
[TBL] [Abstract][Full Text] [Related]
33. Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages.
Taddei RN; Sanchez-Mico MV; Bonnar O; Connors T; Gaona A; Denbow D; Frosch MP; Gómez-Isla T
Acta Neuropathol Commun; 2022 May; 10(1):72. PubMed ID: 35534858
[TBL] [Abstract][Full Text] [Related]
34. Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau.
Klein RL; Lin WL; Dickson DW; Lewis J; Hutton M; Duff K; Meyer EM; King MA
Am J Pathol; 2004 Jan; 164(1):347-53. PubMed ID: 14695347
[TBL] [Abstract][Full Text] [Related]
35. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
Czasch S; Paul S; Baumgärtner W
Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
[TBL] [Abstract][Full Text] [Related]
36. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease.
Mitchell TW; Mufson EJ; Schneider JA; Cochran EJ; Nissanov J; Han LY; Bienias JL; Lee VM; Trojanowski JQ; Bennett DA; Arnold SE
Ann Neurol; 2002 Feb; 51(2):182-9. PubMed ID: 11835374
[TBL] [Abstract][Full Text] [Related]
37. Unusual clinical presentation and neuropathology in two subjects with fused-in sarcoma (FUS) positive inclusions.
Hartikainen PH; Pikkarainen M; Hänninen T; Soininen H; Alafuzoff I
Neuropathology; 2012 Feb; 32(1):60-8. PubMed ID: 21518013
[TBL] [Abstract][Full Text] [Related]
38. Evidence of neurodegeneration in obstructive sleep apnea: Relationship between obstructive sleep apnea and cognitive dysfunction in the elderly.
Daulatzai MA
J Neurosci Res; 2015 Dec; 93(12):1778-94. PubMed ID: 26301370
[TBL] [Abstract][Full Text] [Related]
39. [The molecular pathology of frontotemporal lobar degeneration].
Fujishiro H; Hasegawa M; Arai T
Seishin Shinkeigaku Zasshi; 2010; 112(4):313-24. PubMed ID: 20496755
[TBL] [Abstract][Full Text] [Related]
40. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
